Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
0.993
-0.017 (-1.68%)
At close: Mar 6, 2026, 4:00 PM EST
0.980
-0.013 (-1.31%)
After-hours: Mar 6, 2026, 7:49 PM EST
Hoth Therapeutics Employees
As of December 31, 2024, Hoth Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,961,234
Market Cap
15.41M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Curis | 34 |
| IN8bio | 17 |
| Quantum BioPharma | 17 |
| Serina Therapeutics | 13 |
| Cocrystal Pharma | 11 |
| Quoin Pharmaceuticals | 5 |
| Jupiter Neurosciences | 4 |
| Pasithea Therapeutics | 4 |
HOTH News
- 3 days ago - Hoth Therapeutics Deploys OpenAI API to Advance Development of Orphan HT-KIT Oncology Program - PRNewsWire
- 10 days ago - HOTH THERAPEUTICS ACCELERATES HT-001 TRIAL ENROLLMENT WITH NEW CLINICAL SITE AS PATIENT DEMAND INCREASES - PRNewsWire
- 25 days ago - Hoth Therapeutics Announces Groundbreaking Positive Results: Hoth's HT-VA GDNF Surpasses Semaglutide in Weight Loss, Glucose Control, and Liver Health in Obesity Model - PRNewsWire
- 25 days ago - EXCLUSIVE: Small Biotech Hoth Therapeutics Claims Experimental Obesity Drug Topped Famed Wegovy In Preclinical Study - Benzinga
- 4 weeks ago - Hoth Therapeutics Addresses Market Rumor, Hoth Holds No Crypto Currency Assets - PRNewsWire
- 6 weeks ago - Hoth Therapeutics Delivers 100% Clinical Response with ~50% Reduction in Disease Severity in Open-Label PK Cohort of EGFR-Treated Cancer Patients - PRNewsWire
- 6 weeks ago - Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position - PRNewsWire
- 7 weeks ago - Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing HT-001 Oncology Trial Toward Multi-Country Site Activation - PRNewsWire